LifeGuide

Testing, Testing Serosorting is common for IV drug users who know their HCV status by Larry Buhl A new study shows IV drug users who know...

In February, Swedish Medical Center in Englewood, Colorado, revealed that it told nearly 3,000 former surgery patients that they should get tested for hepatitis...

Hep Talk Hepatitis C Antiviral Telaprevir Moves Closer to Approval by Larry Buhl Researchers in a recent Phase III study are encouraged by the results of a...

Hands-On Approach Reiki promotes emotional and physical wellness by Rob Zukowski In the past, I have discussed different forms of energy work. Shiatsu, for example, being one...

LifeGuide Good News, Bad News The HIV cure front faces disappointment mixed with hope by Jeannie Wraight The past year has been a difficult one in the HIV...

A not-for-profit biotech helps energize the future of TB vaccine R&D by Chael Needle According to the World Health Organization, tuberculosis is the most common illness...

Test Fail Few boomers are getting screened for hep C by Larry Buhl In 2012, the U.S. Centers for Disease Control (CDC) and the U.S. Preventative Services...

Warts & All An immunotherapy candidate seeks to address complications from HPV by Chael Needle Human papillomavirus (HPV) is the most common sexually transmitted infection, but, according...

NAPWA helps to promote immune-based therapies by Chael Needle At the International AIDS Conference last June, the AIDS Institute and the National Association of People with AIDS...

Appointment Viewing Can videoconferencing improve outcomes for hep C patients who have used IV drugs? by Larry Buhl Thanks to a $7 million grant from the Patient-Centered...